These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4151883)

  • 1. Stereochemical studies on medicinal agents. 10. The role of chirality in alpha-adrenergic receptor blockage by (plus)-and(minus)-phenoxybenzamine hydrochloride.
    Portoghese PS; Riley TN; Miller JW
    J Med Chem; 1971 Jul; 14(17):561-4. PubMed ID: 4151883
    [No Abstract]   [Full Text] [Related]  

  • 2. Irreversible adrenergic -receptor antagonism by (R)-and (S)-N-(2-chloroethyl)-N-methyl-2-phenyl-2-hydroxyethylamine and related agents.
    McLean S; Swamy VC; Tomei D; Triggle DJ
    J Med Chem; 1973 Jan; 16(1):54-7. PubMed ID: 4404822
    [No Abstract]   [Full Text] [Related]  

  • 3. "Spare" alpha 1-adrenergic receptors and the potency of agonists in rat vas deferens.
    Minneman KP; Abel PW
    Mol Pharmacol; 1984 Jan; 25(1):56-63. PubMed ID: 6143249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Halogenoethylamines and the role of Ca 2+ in adrenergic -receptor activation in the rat vas deferens.
    Swamy VC; Triggle DJ
    Eur J Pharmacol; 1972 Jul; 19(1):67-78. PubMed ID: 4340228
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: Possible allosteric interaction between pharmacological receptors in guinea-pig vas deferens.
    Iijima AT; Reiffenstein RJ
    Br J Pharmacol; 1972 Feb; 44(2):364P-365P. PubMed ID: 4668626
    [No Abstract]   [Full Text] [Related]  

  • 6. Functional characterization of alpha1-adrenoceptor subtypes in longitudinal and circular muscle of human vas deferens.
    Amobi N; Guillebaud J; Coker C; Mulvin D; Smith IC
    Eur J Pharmacol; 1999 Feb; 367(2-3):291-8. PubMed ID: 10079004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of adrenergic responses by halogenated phenyl-2-halogenoethyl amines.
    Swamy VC
    Life Sci; 1974 Jun; 14(11):2143-50. PubMed ID: 4847806
    [No Abstract]   [Full Text] [Related]  

  • 8. 1,4-Benzodioxanes as reversible and irreversible antagonists at adrenergic receptors.
    Avner BP; Triggle DJ
    J Med Chem; 1974 Feb; 17(2):197-200. PubMed ID: 4148932
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and adrenoreceptor blocking action of aziridinium ions derived from phenoxybenzamine and dibenamine.
    Henkel JG; Portoghese PS; Miller JW; Lewis P
    J Med Chem; 1976 Jan; 19(1):6-10. PubMed ID: 1536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further studies on receptor interaction for the alpha-antagonist WB 4101.
    Kapur H; Green PN; Mottram DR
    J Pharm Pharmacol; 1979 Mar; 31(3):188-9. PubMed ID: 34700
    [No Abstract]   [Full Text] [Related]  

  • 11. Selectivity of blocking agents for pre-and postsynaptic alpha-adrenoceptors.
    Doxey JC; Smith CF; Walker JM
    Br J Pharmacol; 1977 May; 60(1):91-6. PubMed ID: 18248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contractile actions of imidazoline alpha-adrenoceptor agonists and effects of noncompetitive alpha1-adrenoceptor antagonists in human vas deferens.
    Amobi N; Guillebaud J; Kaisary A; Lloyd-Davies RW; Turner E; Smith IC
    Eur J Pharmacol; 2003 Feb; 462(1-3):169-77. PubMed ID: 12591110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sympathetic denervation does not alter the density or properties of alpha-1 adrenergic receptors in rat vas deferens.
    Abel PW; Johnson RD; Martin TJ; Minneman KP
    J Pharmacol Exp Ther; 1985 Jun; 233(3):570-7. PubMed ID: 2989488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin-versus alpha-adrenoceptor-mediated control of sympathetic neurotransmitter secretion in guinea-pig isolated vas deferens.
    Stjärne L
    Eur J Pharmacol; 1973 Jun; 22(3):233-8. PubMed ID: 4147330
    [No Abstract]   [Full Text] [Related]  

  • 15. On the relationship between uptake inhibition and reversal of alpha receptor blockade by propranolol.
    Mottram DR; Hickman JA
    Pharmacol Res Commun; 1979 Oct; 11(9):795-808. PubMed ID: 43520
    [No Abstract]   [Full Text] [Related]  

  • 16. A study of the conformational requirements for direct adrenergic stimulation.
    Gray AP; Reit E; Ackerly JA; Hava M
    J Med Chem; 1973 Sep; 16(9):1023-7. PubMed ID: 4147657
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings: Is thymoxamine a specific alpha-adrenoceptor blocking agent?
    Fawke L
    Br J Pharmacol; 1972 Feb; 44(2):362P-362P. PubMed ID: 4148921
    [No Abstract]   [Full Text] [Related]  

  • 18. The irreversible inhibitory effects of phenoxybenzamine on the noradrenaline-, K- and Ba-induced contractions of rat's isolated vas deferens, particularly in relation to Ca.
    Ogino K
    Kobe J Med Sci; 1976 Sep; 22(3):153-60. PubMed ID: 1021648
    [No Abstract]   [Full Text] [Related]  

  • 19. Interaction of D 600 with phenoxybenzamine-induced adrenergic blockade.
    Nwako N; Lin CS; Swamy VC
    Eur J Pharmacol; 1980 Mar; 62(2-3):205-7. PubMed ID: 7379841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irreversible antagonism at the adrenergic alpha-receptor: the role of calcium.
    Moran JF; Swamy VC; Triggle DJ
    Life Sci I; 1970 Nov; 9(22):1303-15. PubMed ID: 4395119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.